Growth Opportunities in Lancets Market

Lancets Market worth $1,442 million by 2024
According to the new market research report "Lancets Market by Type (Safety Lancets (Push
button, Pressure Activated, Side Button), Personal Lancets), Application (Glucose Testing,
Hemoglobin Testing), End User (Hospital, Clinic, Homecare), Region - Global Forecast to
2024", published by MarketsandMarkets, is projected to grow at a CAGR of 12.4% during the
forecast period to reach USD 1,442 million by 2024 from USD 804 million in 2019.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=86063487
Factors such as the growing prevalence of diabetes and the high prevalence of infectious
diseases are driving the growth of the Lancets Market during the forecast period.
Safety Lancet is expected to be the most widely used type of the Lancets Market
The safety lancets accounted for the largest market share in 2018. This is primarily be
attributed to the advantages associated with safety lancets such as their ease of use, the
capability to prevent needlestick injuries and cross-contamination, and painlessness of vein
puncture. In line with this, According to PharmaJet, in the US, around 600,000 to 800,000
needlestick injuries are reported every year. This is expected to increase the demand of safety
lancets.
Browse and in-depth TOC on "Lancets Market"
75 - Tables
27 - Figures
107 - Pages
Glucose testing segment is expected to account for the largest share of the Lancets Market
application
The glucose testing segment accounted for the largest share of the Lancets Market, by
application, in 2018. This is primarily due to the increasing prevalence of diabetes, and the need
for its prevention and management. For instance, according to the International Diabetes
Federation (IDF), in 2017, there were almost 425 million people suffering from diabetes
worldwide, and this figure is expected to increase to 629 million by 2045. The growing
prevalence of diabetes has resulted in the increased adoption of lancets to effectively handle
the growing patient pool.
Request Research Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=86063487

Asia Pacific to dominate the Lancets Market during the forecast period
In 2018, North America dominated the Lancets Market, followed by Europe. Increasing
prevalence of diabetes and favorable reimbursement scenario in the region are the factors
propelling the growth of the market in the region.
The Asia Pacific region is projected to register the highest growth rate in the global Lancets
Market during the forecast period. This is primarily attributed to the rapid economic growth,
rising awareness about diabetes treatment, rising geriatric population in China and India, and
Japan’s growing healthcare industry.
Prominent players in the Lancets Market are Becton, Dickinson and Company (US), Roche
Diagnostics (Switzerland), Ypsomed (Switzerland), B. Braun Melsungen (Germany), Terumo
Corporation (Japan), Own Mumford (UK), HTL-STREFA S.A (Poland), ARKRAY (Japan), Sarstedt
(Germany), and SteriLance Medical (Suzhou) (China).
Browse Related Reports:
Pen Needles Market by Type (Standard Pen Needles and Safety Pen Needles), Needle Length
(4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP-1, Growth Hormone, and
Others), Mode of Purchase (Retail, Non-Retail) - Global Forecasts to 2023
Blood Glucose Monitoring System Market by Product (Self-Monitoring, Continuous Glucose
Monitoring Devices), Testing Site (Fingertip), Patient Care Setting (Hospital, Homecare),
Application (Type 1, Type 2, Gestational Diabetes) - Global Forecast to 2022
Blood Collection Market by Product (Serum Tube, Plasma Tube, EDTA, Heparin, Coagulation,
Glucose, Needle, Lancet, ESR, Syringe, Blood Bag), Method (Manual, Automated), End User
(Hospital, Blood Bank Center, Academics, Home Care) - Global Forecast to 2022
About MarketsandMarkets:
MarketsandMarkets provides quantified B2B research on 30,000 high growth niche
opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues.
Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies
as clients. Almost 75,000 top officers across eight industries worldwide approach
MarketsandMarkets for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth
markets following the "Growth Engagement Model – GEM". The GEM aims at proactive
collaboration with the clients to identify new opportunities, identify most important customers,
write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both
the company and its competitors. MarketsandMarkets now coming up with 1,500
MicroQuadrants (Positioning top players across leaders, emerging companies, innovators,
strategic players) annually in high growth emerging segments. MarketsandMarkets is
determined to benefit more than 10,000 companies this year for their revenue planning and help
them take their innovations/disruptions early to the market by providing them research ahead
of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform,
"Knowledge Store" connects over 200,000 markets and entire value chains for deeper
understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
Email: sales@marketsandmarkets.com
Content Source: https://www.marketsandmarkets.com/PressReleases/lancets.asp
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/lancets-market.asp
Visit Our Website: https://www.marketsandmarkets.com